2.92
price down icon3.31%   -0.10
 
loading
前日終値:
$3.02
開ける:
$3.02
24時間の取引高:
140.99K
Relative Volume:
3.70
時価総額:
$76.60M
収益:
$6.21M
当期純損益:
$-19.92M
株価収益率:
-1.4974
EPS:
-1.95
ネットキャッシュフロー:
$-16.76M
1週間 パフォーマンス:
+10.61%
1か月 パフォーマンス:
+19.18%
6か月 パフォーマンス:
+14.96%
1年 パフォーマンス:
+17.27%
1日の値動き範囲:
Value
$2.62
$3.1299
1週間の範囲:
Value
$2.5516
$3.15
52週間の値動き範囲:
Value
$1.81
$3.42

InspireMD Inc. Stock (NSPR) Company Profile

Name
名前
InspireMD Inc.
Name
セクター
Healthcare (1200)
Name
電話
972 3 6917691
Name
住所
4 Menorat Hamaor Street, Tel Aviv
Name
職員
36
Name
Twitter
@InspireMD
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
NSPR's Discussions on Twitter

NSPR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
NSPR
InspireMD Inc.
2.92 76.60M 6.21M -19.92M -16.76M -1.95
Medical Devices icon
ABT
Abbott Laboratories
118.95 208.18B 41.22B 5.77B 6.49B 2.94
Medical Devices icon
SYK
Stryker Corp
388.14 148.70B 21.97B 3.59B 3.21B 6.74
Medical Devices icon
BSX
Boston Scientific Corp
90.75 133.32B 15.91B 1.79B 1.89B 0.82
Medical Devices icon
MDT
Medtronic Plc
86.27 111.27B 33.00B 4.29B 5.50B 2.71
Medical Devices icon
EW
Edwards Lifesciences Corp
72.07 42.66B 6.60B 4.16B 490.10M 2.34

InspireMD Inc. Stock (NSPR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2016-01-07 開始されました Rodman & Renshaw Buy
2015-03-13 ダウングレード Oppenheimer Outperform → Perform
2013-11-26 開始されました Oppenheimer Outperform

InspireMD Inc. (NSPR) 最新ニュース

pulisher
Nov 26, 2024

InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com - Defense World

Nov 26, 2024
pulisher
Nov 26, 2024

InspireMD appoints Scott R. Ward to its Board - Medical Buyer

Nov 26, 2024
pulisher
Nov 26, 2024

InspireMD adds medtech veteran Scott Ward to its board By Investing.com - Investing.com Nigeria

Nov 26, 2024
pulisher
Nov 26, 2024

InspireMD Appoints Scott R. Ward to Board of Directors - Defense World

Nov 26, 2024
pulisher
Nov 25, 2024

InspireMD, Inc. Appoints Scott R. Ward to Its Board of Directors - Marketscreener.com

Nov 25, 2024
pulisher
Nov 25, 2024

InspireMD adds medtech veteran Scott Ward to its board - Investing.com

Nov 25, 2024
pulisher
Nov 25, 2024

InspireMD Strengthens Leadership with Scott R. Ward Appointment - TipRanks

Nov 25, 2024
pulisher
Nov 25, 2024

InspireMD Announces Appointment of Accomplished Medical - GlobeNewswire

Nov 25, 2024
pulisher
Nov 25, 2024

InspireMD Strengthens Board with Ex-Medtronic Executive Ahead of CGuard Prime FDA Decision | NSPR Stock News - StockTitan

Nov 25, 2024
pulisher
Nov 18, 2024

InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - Defense World

Nov 18, 2024
pulisher
Nov 18, 2024

StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - MarketBeat

Nov 18, 2024
pulisher
Nov 14, 2024

InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 14, 2024
pulisher
Nov 14, 2024

InspireMD Inc (NSPR) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 14, 2024

InspireMD Third Quarter 2024 Earnings: US$0.16 loss per share (vs US$0.15 loss in 3Q 2023) - Yahoo Finance

Nov 14, 2024
pulisher
Nov 13, 2024

InspireMD, Inc. (NASDAQ:NSPR) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

InspireMD Inc. Faces Financial Uncertainty Amidst Ongoing Losses and Cash Flow Challenges - TipRanks

Nov 13, 2024
pulisher
Nov 12, 2024

InspireMD Inc. Reports Q3 2024 Financial Results - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

InspireMD Achieves Record Q3 Revenue with CGuard Success - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

InspireMD Sets Revenue Record, Files FDA Approval for CGuard Stent Amid Wider Losses | NSPR Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

InspireMD Inc (NSPR) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Costs and ... By GuruFocus - Investing.com Canada

Nov 12, 2024
pulisher
Nov 11, 2024

What To Expect From InspireMD Inc (NSPR) Q3 2024 Earnings - Yahoo Finance

Nov 11, 2024
pulisher
Nov 11, 2024

InspireMD announces inducement grants - Medical Buyer

Nov 11, 2024
pulisher
Nov 10, 2024

InspireMD (NYSE:NSPR) Earns Sell Rating from Analysts at StockNews.com - MarketBeat

Nov 10, 2024
pulisher
Nov 08, 2024

Inspiremd Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - XM

Nov 08, 2024
pulisher
Nov 08, 2024

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Nov 08, 2024
pulisher
Nov 05, 2024

InspireMD (NSPR) to Release Quarterly Earnings on Tuesday - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

InspireMD to Report Third Quarter 2024 Financial Results - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12th - The Manila Times

Nov 04, 2024
pulisher
Nov 02, 2024

StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - MarketBeat

Nov 02, 2024
pulisher
Oct 28, 2024

Rosalind Advisors, Inc. Acquires Shares in InspireMD Inc - GuruFocus.com

Oct 28, 2024
pulisher
Oct 21, 2024

One InspireMD Insider Raised Stake By 13% In Previous Year - Yahoo Finance

Oct 21, 2024
pulisher
Oct 17, 2024

InspireMD (NYSE:NSPR) Research Coverage Started at StockNews.com - MarketBeat

Oct 17, 2024
pulisher
Oct 15, 2024

10+ things to know in #MiamiTech: News from InspireMD, 1NCE, Flow, UrbanLink, Carve Communications, Miami Dade College, Aleph, Taxfyleand lots of opportunities! - Refresh Miami

Oct 15, 2024
pulisher
Oct 15, 2024

InspireMD Expands with New Miami Headquarters - TipRanks

Oct 15, 2024
pulisher
Oct 15, 2024

InspireMD Announces Establishment of Global Headquarters in - GlobeNewswire

Oct 15, 2024
pulisher
Oct 15, 2024

InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System - StockTitan

Oct 15, 2024
pulisher
Oct 10, 2024

InspireMD Gains FDA Premarket Approval for CGuard Prime Carotid Stent - Yahoo Finance

Oct 10, 2024
pulisher
Oct 09, 2024

InspireMD (NSPR) Price Target Increased by 11.49% to 4.95 - MSN

Oct 09, 2024
pulisher
Oct 09, 2024

InspireMD (NYSE:NSPR) Receives New Coverage from Analysts at StockNews.com - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

InspireMD Advances with FDA Study Approval and Global Goals - Yahoo Finance

Oct 08, 2024
pulisher
Oct 07, 2024

FDA approves InspireMD's pivotal carotid stent study - Investing.com

Oct 07, 2024
pulisher
Oct 07, 2024

FDA approves InspireMD's pivotal carotid stent study By Investing.com - Investing.com Australia

Oct 07, 2024
pulisher
Oct 07, 2024

InspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System - The Manila Times

Oct 07, 2024
pulisher
Oct 07, 2024

InspireMD Announces Approval of Investigational Device - GlobeNewswire

Oct 07, 2024
pulisher
Oct 04, 2024

Recent Investment Analysts’ Ratings Updates for InspireMD (NSPR) - Defense World

Oct 04, 2024
pulisher
Oct 01, 2024

InspireMD Launches New Employee Inducement Plan - Investing.com

Oct 01, 2024
pulisher
Oct 01, 2024

InspireMD Launches 2024 Plan to Attract Talent with Stock - TipRanks

Oct 01, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Sells 39,856 Shares of InspireMD, Inc. (NYSE:NSPR) - Defense World

Oct 01, 2024

InspireMD Inc. (NSPR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices STE
$217.47
price up icon 0.65%
medical_devices ZBH
$112.02
price up icon 1.25%
medical_devices PHG
$27.15
price up icon 0.89%
$78.10
price up icon 0.21%
$83.00
price up icon 0.59%
medical_devices EW
$72.07
price up icon 0.73%
大文字化:     |  ボリューム (24 時間):